EUDA Health Holdings (EUDAW) Research & Development (2022 - 2023)
EUDA Health Holdings (EUDAW) posted quarterly Research & Development of -$27299.0 for Q2 2023, down 109.66% year-over-year from $282708.0 in Q2 2022, and down 106.74% quarter-over-quarter from $404771.0 in Q1 2023.
EUDA Health Holdings (EUDAW) Research & Development (2022 - 2023) Analysis & Trends
EUDA Health Holdings (EUDAW) has reported Research & Development for 2 consecutive years, with -$27299.0 the latest figure, recorded in Q2 2023.
- In Q2 2023, Research & Development fell 109.66% year-over-year to -$27299.0; the TTM figure through Jun 2023 stood at $1.0 million (changed N/A YoY), while the FY2025 annual figure was $1.3 million, up 888.54% from the prior year.
- Research & Development retreated to -$27299.0 in Q2 2023 per EUDAW's latest filing, from $404771.0 in the prior quarter.
- Across five years, Research & Development topped out at $404771.0 in Q1 2023 and bottomed at -$27299.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Cbre | 44.30 Bn | 42.81 Bn | 2.09 Bn | - |
| 2 | KE Holdings | 18.87 Bn | 15.99 Bn | 661.06 Mn | -156.88 Mn |
| 3 | Jones Lang Lasalle | 17.79 Bn | 17.34 Bn | - | - |
| 4 | Costar | 13.04 Bn | 11.78 Bn | 728.00 Mn | 395.00 Mn |
| 5 | Compass | 9.00 Bn | 8.31 Bn | 3.88 Bn | 109.00 Mn |
| 6 | FirstService | 6.55 Bn | 6.32 Bn | 480.66 Mn | - |
| 7 | Colliers International | 5.46 Bn | 5.40 Bn | 635,105.00 Bn | - |
| 8 | Cushman & Wakefield | 3.45 Bn | 2.95 Bn | 512.00 Mn | - |
| 9 | Opendoor Technologies | 3.35 Bn | 2.45 Bn | 86.00 Mn | 65.00 Mn |
| 10 | EUDA Health Holdings | 55,844.71 | -289,300.29 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -27,299.00 |
| Mar 31, 2023 | 404,771.00 |
| Jun 30, 2022 | 282,708.00 |
| Mar 31, 2022 | 368,092.00 |